Factitious thyrotoxicosis induced by mesotherapy: A case report

Thyroid

Volumn 18, Issue 6, 2008, Pages 655-657

  Danilovic, Debora Lucia Seguro ^a   Bloise, Walter ^a   Knobel, Meyer ^a   Marui, Suemi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CARNITINE; GINKGO BILOBA EXTRACT; GREEN TEA EXTRACT; LIOTHYRONINE; PENTOXIFYLLINE; THYROGLOBULIN; THYROTROPIN; THYROXINE; TIRATRICOL; TRIMECAINE; VASOACTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; ENZYME ACTIVITY; FEMALE; HOMEOPATHY; HUMAN; LIOTHYRONINE BLOOD LEVEL; MESOTHERAPY; PARACRINE SIGNALING; PRIORITY JOURNAL; SKIN FIBROBLAST; THALASSEMIA; THYROGLOBULIN BLOOD LEVEL; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 46349104659     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0233     Document Type: Article

References (20)

1. Rotunda AM, Kolodney MS 2006 Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 32:465-480.
2. Scotini E, Carpenedo F, Fassina G 1983 New derivatives of methyl-xanthines: effect of thiocaffeine thiotheophylline and 8-phenyltheophylline on lipolysis and on phosphodiesterase activities. Pharmacol Res Commun 15:131-143.
3. Nencini P 1980 Differences in the lipolytic and cyclic AMP accumulative action of noradrenaline-theophylline and norephedrine-theophylline. Arzneimittelforschung 30:1080-1082.
4. Matuszek M 1976 Studies on antilipolytic activity of antipyretics. Part II. Influence of sodium salicylate, aminophenazone, and acetophenidin on lipolysis stimulated by noradrenaline and aminophylline in vitro. Pol J Pharmacol Pharm 28:437-442.
5. Iwao N, Oshida Y, Sato Y 1997 Regional difference in lipolysis caused by a beta-adrenergic agonist as determined by the microdialysis technique. Acta Physiol Scand 161:481-487.
6. Nedvidkova J, Haluzik M, Bartak V, Dostalova I, Vlcek P, Racek P, Taus M, Behanova M, Svacina S, Alesci S, Pacak K 2004 Changes of noradrenergic activity and lipolysis in the subcutaneous abdominal adipose tissue of hypo- and hyperthyroid patients: an in vivo microdialysis study. Ann N Y Acad Sci 1018:541-549.
7. Otto W, Taylor TG, York DA 1976 Glycerol release in vitro from adipose tissue of obese (ob/ob) mice treated with thyroid hormones. J Endocrinol 71:143-155.
8. Chopra IJ, Sabatino L 2000 Nature and source of circulating thyroid hormones. In: Braverman LE, Utiger RD (ed) Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott Williams & Wilkins, Philadelphia, pp 121-135.
9. Safer JD, Crawford TM, Fraser LM, Hoa M, Ray S, Chen TC, Persons K, Holick MF 2003 Thyroid hormone action on skin: diverging effects of topical versus intraperitoneal administration. Thyroid 13:159-165.
10. Safer JD, Fraser LM, Ray S, Holick MF 2001 Topical triiodothyronine stimulates epidermal proliferation, dermal thickening, and hair growth in mice and rats. Thyroid 11:717-724.
11. Yazdanparast P, Carlsson B, Oikarinen A, Risteli J, Lavin T, Faergemann J 2006 Action of topical thyroid hormone analogue, triiodothyroacetic acid in reversing glucocorticoid-induced skin atrophy in humans. Thyroid 16:1157-1162.
12. Santini F, Vitti P, Chiovato L, Ceccarini G, Macchia M, Montanelli L, Gatti G, Rosellini V, Mammoli C, Martino E, Chopra IJ, Safer JD, Braverman LE, Pinchera A 2003 Role for inner ring deiodination preventing transcutaneous passage of thyroxine. J Clin Endocrinol Metab 88:2825-2830.
13. DelGuerra P, Caraccio N, Simoncini M, Monzani F 1992 Occupational thyroid disease. Int Arch Occup Environ Health 63:373-375.
14. Friedel J, Piemont Y, Truchetet F, Cattan E 1987 Mesotherapy and cutaneous mycobacteriosis caused by Mycobacterium fortuitum: alternative medicine at risk. [In French.] Ann Dermatol Venereol 114:845-849.
15. Centers for Disease Control and Prevention 2005 Outbreak of mesotherapy-associated skin reactions - District of Columbia area, January-February 2005. MMWR Morb Mortal Wkly Rep 54:1127-1130.
16. Bessis D, Guilhou JJ, Guillot B 2004 Localized urticaria pigmentosa triggered by mesotherapy. Dermatology 209:343-344.
17. Urbani CE 1994 Urticarial reaction to ethylenediamine in aminophylline following mesotherapy. Contact Dermatitis 31:198-199.
18. Lee DP, Chang SE 2005 Subcutaneous nodules showing fat necrosis owing to mesotherapy. Dermatol Surg 31:250-251.
19. Rosina P, Chieregato C, Miccolis D, D'Onghia FS 2001 Psoriasis and side-effects of mesotherapy. Int J Dermatol 40:581-583.
20. Brandao C, Fernandes N, Mesquita N, Dinis-Ribeiro M, Silva R, Lomba Viana H, Moreira Dias L 2005 Abdominal haematoma - a mesotherapy complication. Acta Derm Venereol 85:446.